CIK 0002023658 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Bicara Therapeutics Inc.
Sign in to watch- Ticker
- BCAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-468-4219
- Business address
- 116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $400,716
- in 1 filing, $401K under 10b5-1 plans
Net −$400,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-16 | Biocon Ltd 10% owner | Conversion · Series Seed Redeemable Convertible Preferred Stock | −40,000,000 | 0 | ||
| 2024-09-16 | Biocon Ltd 10% owner | Conversion · Series Seed Redeemable Convertible Preferred Stock | −9,990,144 | 0 | ||
| 2024-09-16 | Mazumdar-Shaw Kiran Director | Conversion | +4,327,365 | 4,443,122 | ||
| 2024-09-16 | Mazumdar-Shaw Kiran Director | Conversion | +1,080,775 | 1,080,775 | ||
| 2024-09-16 | Mazumdar-Shaw Kiran Director | Conversion | +324,552 | 324,552 | ||
| 2024-09-16 | Mazumdar-Shaw Kiran Director | Conversion | +432,736 | 432,736 | ||
| 2024-09-16 | Mazumdar-Shaw Kiran Director | Conversion · Series Seed Redeemable Convertible Preferred Stock | −40,000,000 | 0 | ||
| 2024-09-16 | Mazumdar-Shaw Kiran Director | Conversion · Series Seed Redeemable Convertible Preferred Stock | −9,990,144 | 0 | ||
| 2024-09-16 | Mazumdar-Shaw Kiran Director | Conversion · Series Seed Redeemable Convertible Preferred Stock | −3,000,000 | 0 | ||
| 2024-09-16 | Mazumdar-Shaw Kiran Director | Conversion · Series Seed Redeemable Convertible Preferred Stock | −4,000,000 | 0 | ||
| 2024-09-12 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +23,746 | 23,746 | ||
| 2024-09-12 | LONBERG NILS Director | Grant or award · Stock Option (Right to Buy) | +23,746 | 23,746 | ||
| 2024-09-12 | Simson Jake Director | Grant or award · Stock Option (Right to Buy) | +23,746 | 23,746 | ||
| 2024-09-12 | Haviland Kate Director | Grant or award · Stock Option (Right to Buy) | +23,746 | 23,746 | ||
| 2024-09-12 | Robertson Scott M. Director | Grant or award · Stock Option (Right to Buy) | +23,746 | 23,746 | ||
| 2024-09-12 | Mazumdar-Shaw Kiran Director | Grant or award · Stock Option (Right to Buy) | +23,746 | 23,746 |
Page 14 of 14 · 276 trades